Detailed description of the mediation analyses
Mediation analyses can be used to investigate whether the association between a variable of interest and the outcome can be explained by a third variable, which is referred to as a mediator. In mediation analyses the total effect (c) of the variable of interest on the outcome is therefore divided into a direct effect (c') and an indirect effect through the mediator (a*b), which is the result of the effect of the variable of interest on the mediator (a) and the effect of the mediator on the outcome (b) (Supplementary Figure S3 ). To establish mediation, we performed mediation analysis in R using the mediation package. 1 First, we estimated the total effect of total BCAA on PTDM (c) using regression analysis. Subsequently we estimated the effect of total BCAA on plasma glucose and HbA1c (a). We estimated the effect of plasma glucose and HbA1c as potential mediators on the PTDM were estimated (b). The indirect effect of plasma glucose and HbA1c was then calculated by computing the product of the 2 regression coefficients of the potential mediator and total BCAA and PTDM (a*b). The magnitude of indirect effects was calculated by dividing the coefficient of the indirect effects by the total effect. All mediation analyses were adjusted for age and sex. Significance of mediation was tested by computing bias-corrected bootstrap CIs with 2,000 repetitions. 1.00 0.65 Cox proportional hazards regression analyses were performed to assess the association of BCAAs with all-cause mortality and death-censored graft failure. Model 1: adjustment for age and sex; model 2: model 1 + adjustment for eGFR, proteinuria, and time since transplantation; model 3: model 2 + adjustment for total cholesterol and triglycerides; model 4: model 2 + adjustment for total energy intake, physical activity, and BMI; model 5: model 2 + adjustment for smoking status and alcohol intake; model 6: model 2 + adjustment for prednisolone dose and trough levels of tacrolimus and cyclosporine. BCAA, branched chain amino acids; PTDM, post-transplant diabetes mellitus; eGFR, estimated glomerular filtration rate
